Retracted: MiR-373 Inhibits the Epithelial-Mesenchymal Transition of Prostatic Cancer via Targeting Runt-Related Transcription Factor 2

Detalles Bibliográficos
Autor principal: Healthcare Engineering, Journal of
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Retraction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10447104/
https://www.ncbi.nlm.nih.gov/pubmed/37621633
http://dx.doi.org/10.1155/2023/9836954
_version_ 1785094478559707136
author Healthcare Engineering, Journal of
author_facet Healthcare Engineering, Journal of
author_sort Healthcare Engineering, Journal of
collection PubMed
description
format Online
Article
Text
id pubmed-10447104
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-104471042023-08-24 Retracted: MiR-373 Inhibits the Epithelial-Mesenchymal Transition of Prostatic Cancer via Targeting Runt-Related Transcription Factor 2 Healthcare Engineering, Journal of J Healthc Eng Retraction Hindawi 2023-08-16 /pmc/articles/PMC10447104/ /pubmed/37621633 http://dx.doi.org/10.1155/2023/9836954 Text en Copyright © 2023 Journal of Healthcare Engineering. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Retraction
Healthcare Engineering, Journal of
Retracted: MiR-373 Inhibits the Epithelial-Mesenchymal Transition of Prostatic Cancer via Targeting Runt-Related Transcription Factor 2
title Retracted: MiR-373 Inhibits the Epithelial-Mesenchymal Transition of Prostatic Cancer via Targeting Runt-Related Transcription Factor 2
title_full Retracted: MiR-373 Inhibits the Epithelial-Mesenchymal Transition of Prostatic Cancer via Targeting Runt-Related Transcription Factor 2
title_fullStr Retracted: MiR-373 Inhibits the Epithelial-Mesenchymal Transition of Prostatic Cancer via Targeting Runt-Related Transcription Factor 2
title_full_unstemmed Retracted: MiR-373 Inhibits the Epithelial-Mesenchymal Transition of Prostatic Cancer via Targeting Runt-Related Transcription Factor 2
title_short Retracted: MiR-373 Inhibits the Epithelial-Mesenchymal Transition of Prostatic Cancer via Targeting Runt-Related Transcription Factor 2
title_sort retracted: mir-373 inhibits the epithelial-mesenchymal transition of prostatic cancer via targeting runt-related transcription factor 2
topic Retraction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10447104/
https://www.ncbi.nlm.nih.gov/pubmed/37621633
http://dx.doi.org/10.1155/2023/9836954
work_keys_str_mv AT healthcareengineeringjournalof retractedmir373inhibitstheepithelialmesenchymaltransitionofprostaticcancerviatargetingruntrelatedtranscriptionfactor2

Ejemplares similares